SCHEMBL9656608

SCHEMBL9656608

CCCOC(=O)Oc1c(OC)c(OC)c(OC(=O)OCCC)c2ccccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2C9 P11712 1/20 0.47
IDO1 P14902 1/20 0.47
ALDH1A1 P00352 4/20 0.46
LMNA P02545 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.44
MAPK1 P28482 1/20 0.44
MAOB P27338 2/20 0.43
ALOX5 P09917 1/20 0.41
HSD17B10 Q99714 2/20 0.40
SCN5A Q14524 1/20 0.39
SCN9A Q15858 1/20 0.39
SCN10A Q9Y5Y9 1/20 0.39
ABCB11 O95342 1/20 0.39
TOP2A P11388 1/20 0.38
GAA P10253 1/20 0.38
ELANE P08246 3/20 0.37
HPGD P15428 1/20 0.37
CA12 O43570 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9657849 0.91 KDM4E (0.43) KDM4ECYP1A2CYP2C9IDO1ALDH1A1
SCHEMBL9656655 0.91 TSHR (0.49) KDM4ECYP1A2CYP2C9IDO1ALDH1A1
SCHEMBL19583364 0.90 ALDH1A1 (0.52) KDM4EALDH1A1LMNASMN1; SMN2MAPK1
SCHEMBL30003343 0.90 ALDH1A1 (0.52) KDM4EALDH1A1LMNASMN1; SMN2MAPK1
SCHEMBL9656385 0.89 ALOX5 (0.42) KDM4ECYP1A2CYP2C9IDO1ALDH1A1
SCHEMBL9657048 0.88 TSHR (0.51) KDM4ECYP1A2CYP2C9IDO1ALDH1A1
SCHEMBL9658008 0.87 ALDH1A1 (0.46) KDM4ECYP1A2CYP2C9IDO1ALDH1A1
SCHEMBL9657879 0.87 KDM4E (0.50) KDM4ECYP1A2CYP2C9IDO1ALDH1A1
SCHEMBL9658456 0.86 ALDH1A1 (0.45) KDM4ECYP1A2CYP2C9IDO1ALDH1A1
SCHEMBL9659599 0.84 KDM4E (0.42) KDM4EALDH1A1LMNAMAOBALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5134161-A Enzyme inhibitors for skin disorders, antiinflammatory agents SYNTEX (U.S.A.) INC. (US) 1992-07-28 US disclosed
US-4786652-A TOPICAL ADMINISTRATION SYNTEX (U.S.A.) INC. (US) 1988-11-22 US disclosed
EP-0282006-A1 Naphtalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1988-09-14 EP disclosed